Watchman Group’s ResMed RMD Stock Holding History

Watchman Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,830	Closed	-$2.85M	–	76
2025 Q4	$2.85M	Sell	11,830 -326	-3%	-$83.4K	0.68%	41
2025 Q3	$3.33M	Sell	12,156 -385	-3%	-$105K	0.81%	39
2025 Q2	$3.24M	Sell	12,541 -470	-4%	-$112K	0.84%	39
2025 Q1	$2.91M	Buy	+13,011	New	+$3.04M	0.82%	41

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Watchman Group's RMD Position: Q1 2026 in Review

Watchman Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 11,830 shares — an estimated $2.85M sold.

Watchman Group first reported a position in RMD in Q1 2025 and held it in 4 quarters. The position peaked at $3.33M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Watchman Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Watchman Group sold 11,830 ResMed shares in Q1 2026, an estimated $2.85M.
Watchman Group first reported a position in ResMed in Q1 2025 and held it in 4 quarters.
Watchman Group's ResMed position peaked at $3.33M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Watchman Group's 13F filing for Q1 2026, filed 20 Apr 2026.